Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.615
-0.025 (-1.52%)
Mar 31, 2025, 2:35 PM EDT - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $57.96 million as of March 31, 2025. Its market cap has decreased by -66.34% in one year.
Market Cap
57.96M
Enterprise Value
26.87M
1-Year Change
-66.34%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $57.96M, a decrease of -84.16%. That is a compound annual growth rate of -39.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 58.86M | -13.84% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |